Legal Representation
Attorney
Maureen E. Kelly
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 27, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 27, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 18, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 18, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 18, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 18, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Apr 25, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 28, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 28, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 8, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 23, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 17, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 17, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 17, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 17, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 17, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 5, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 26, 2022 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 25, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 14, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 041
Educational services, namely, conducting classes and seminars in the field of oncological disease
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Providing medical information relating to oncological diseases and pharmaceuticals used to treat oncological diseases, as well as medical information to help support ongoing compliance and adherence to oncological disease therapies, and to enhance patients' knowledge of oncological diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of word "Slayback" in black, above "CONNECT" in red (Pantone 202) with a gray (Pantone Cool Gray 3 C) molecule figure representing the "O", centered in a partial, rectangular shaped box in gray (Pantone Cool Gray 3 C).
Color Claim
The color(s) gray (or Pantone Cool Gray 3 C), red (or Pantone 202) and black is/are claimed as a feature of the mark.
Pseudo Mark
SLAY BACK CONNECT
Classification
International Classes
041
044